Universal Copy Service: One Shared Component, Many Sequencers

Case at a glance

Case number

046

Date / range

2023 disclosure

Sector

Genomic cybersecurity and infrastructure

Genetic asset

Shared instrument software and configuration

Security principle

Shared-Component Blast Radius

Event summary

The 2023 Illumina Universal Copy Service disclosure showed how one privileged software component embedded across multiple sequencing instruments can create a fleet-wide attack surface capable of affecting settings, software, or genomic results.

Source: fda.gov — Illumina Universal Copy Service Vulnerability source 1.

Source: cisa.gov — Illumina Universal Copy Service Vulnerability source 2.

The case in context

Universal Copy Service illustrates risk inherited through a component used across several products. A device-by-device inventory can miss that relationship if it records only instrument model names and not the shared software beneath them.

The reported potential effects should not be rewritten as confirmed patient harm or data theft. The case instead shows why coordinated component inventories and remediation matter. Teams need a way to connect a shared-component notice to the instruments they operate and the runs whose processing history may need attention.

Acquisition and processing

common privileged service → remotely reachable vulnerability → code execution or configuration change → multi-instrument impact → potential result manipulation

The sequence of events

1. common privileged service
2. remotely reachable vulnerability
3. code execution or configuration change
4. multi-instrument impact
5. potential result manipulation

What became inferable or exposed

Shared instrument software and configuration

The 2023 Illumina Universal Copy Service disclosure showed how one privileged software component embedded across multiple sequencing instruments can create a fleet-wide attack surface capable of affecting settings, software, or genomic results.

Affected parties and consent

Direct parties

Operators of potentially affected sequencing instruments

Indirect parties

Connected institutions, communities, or resource users; no affected-person total is assigned.

Direct count

Unknown / not assigned

Indirect count

Unknown / not assigned

Consent status

Legitimate instrument access does not authorize compromise. Vulnerability notices and research demonstrations are not evidence of consent violations against a known victim group.

Security dimensions

Confidentiality

The confidentiality question concerns shared instrument software and configuration. Exposure and further inference must be distinguished from the fact of collection or availability.

Integrity

The integrity question is whether the described material, permissions, processing, or interpretation can be relied upon. Shared-Component Blast Radius identifies the particular boundary examined here.

Availability

Access and continuity are assessed for the described event; potential effects are not presented as confirmed outages or losses.

Provenance

The relevant chain follows shared instrument software and configuration through the stages shown below. Missing public detail is not proof that internal records did not exist.

Consent, persistence, and relational exposure

Consent

Legitimate instrument access does not authorize compromise. Vulnerability notices and research demonstrations are not evidence of consent violations against a known victim group.

Persistence

Later reuse depends on the actual asset and links to other records; no future misuse is asserted.

Relational exposure

Connected institutions, communities, or resource users; no affected-person total is assigned.

Case-specific assessment

integrity/provenance critical; confidentiality and availability high; supply-chain scope high.

GeneticSecurity.org analysis

Proposed classification and its limits

Suggested GER: GER-3/4. Suggested GPR: GPR-5 for exfiltrated sequence data. Suggested GPI: GPI-0/1 for affected runs until validated.

These are proposed classifications from the supplied case dossier. Conditional scores describe an assumed exposure; they are not evidence that it occurred. A single numeric value is left unassigned when the asset or outcome is not sufficiently bounded.

What this case does not prove

The vulnerability disclosure does not establish exploitation, patient harm, or altered results.

Mitigations and lessons

• Software bill of materials
• Shared-component inventory
• Coordinated disclosure
• Rapid fleet patching
• Signed software
• Instrument isolation
• Integrity monitoring
• Run-level provenance attestation

Primary sources

• PRIMARY SOURCE fda.gov — Illumina Universal Copy Service Vulnerability source 1
• PRIMARY SOURCE cisa.gov — Illumina Universal Copy Service Vulnerability source 2

Secondary sources

No additional source listed. See the evidence notes for limitations.

Related concepts

• Genetic Exposure Radius — Scope of relational exposure
• Genetic Persistence Risk — Durability after compromise
• Genetic Provenance Integrity — Verifiability of the chain of custody

Related cases

• Case 008 — Compare Genomic laboratory ransomware for genomic infrastructure compromise. This case focuses on shared-component blast radius.
• Case 045 — Compare Illumina Local Run Manager Vulnerabilities for instrument software is part of the genome. This case focuses on shared-component blast radius.
• Case 047 — Compare DNA-Encoded Malware Proof Of Concept for cross-domain input validation. This case focuses on shared-component blast radius.

Policy and standards

Review and correction history

Source edition: September 19, 2026. Imported case account; no substantive corrections recorded.

Cite this case

GS-CASE-046. Universal Copy Service: One Shared Component, Many Sequencers. GeneticSecurity.org. https://geneticsecurity.org/cases/046-illumina-universal-copy-service-vulnerability/